Wellington Management Amends Cytokinetics Stake on Dec 29

TL;DR

**Wellington Management Group LLP updated its Cytokinetics stake, signaling a potential shift in institutional confidence.**

AI Summary

Wellington Management Group LLP, a major investment firm, filed an amended SC 13G/A on February 8, 2024, indicating a change in their beneficial ownership of Cytokinetics, Incorporated's common stock as of December 29, 2023. This filing, an amendment to a previous disclosure, signals that Wellington Management Group LLP continues to hold a significant, though potentially adjusted, stake in Cytokinetics. For investors, this matters because large institutional holdings can influence stock stability and signal confidence (or lack thereof) in the company's future prospects.

Why It Matters

This filing shows that a major institutional investor, Wellington Management Group LLP, has updated its position in Cytokinetics, which can impact market perception and liquidity for the stock.

Risk Assessment

Risk Level: low — This is a routine amendment filing by an institutional investor, not indicating any immediate high-risk event for the company.

Analyst Insight

Investors should monitor subsequent filings from Wellington Management Group LLP to understand the exact change in their stake, as this amendment only indicates an update, not the specific increase or decrease in shares. This could signal a re-evaluation of Cytokinetics by a major institutional holder.

Key Players & Entities

• Wellington Management Group LLP (company) — the reporting person and institutional investor
• Cytokinetics, Incorporated (company) — the subject company whose securities are being reported
• Massachusetts (company) — place of organization for Wellington Management Group LLP
• December 29, 2023 (date) — date of the event requiring the filing
• February 8, 2024 (date) — date the SC 13G/A was filed

FAQ

Filing Documents

• SEC13G_Filing.htm (SC 13G/A) — 35KB
• 0000902219-24-000063.txt ( ) — 37KB

From the Filing

SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 ) * Cytokinetics, Incorporated (Name of Issuer) Common Stock (Title of Class of Securities) 23282W605 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 23282W605 1. NAMES OF REPORTING PERSONS Wellington Management Group LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,036,013 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,530,884 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,530,884 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.66% 12. TYPE OF REPORTING PERSON HC CUSIP No. 23282W605 1. NAMES OF REPORTING PERSONS Wellington Group Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,036,013 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,530,884 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,530,884 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.66% 12. TYPE OF REPORTING PERSON HC CUSIP No. 23282W605 1. NAMES OF REPORTING PERSONS Wellington Investment Advisors Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 6,036,013 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,530,884 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,530,884 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.66% 12. TYPE OF REPORTING PERSON HC CUSIP No. 23282W605 1. NAMES OF REPORTING PERSONS Wellington Management Company LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 5,998,852 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 6,325,032 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 6,325,032 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.45% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer Cytokinetics, Incorporated (b) Address of Issuer's Principal Executive Offices 350 Oyster Point Boulevard South San Francisco, CA 94080 Item 2. (a) Name of Person Filing Wellington Management Group LLP Wellington Group Holdings LLP Wellington Investment Advisors Holdings LLP Wellington Management Company LLP (b) Address of Principal Business Office or, if None, Residence c/o Wellington Management Company LLP 280 Congress Street Boston, MA 02210 (c) Citizenship Wellington Management Group LLP - Massachusetts Wellington Group Holdings LLP - Delaware Wellington Investment Advisors Holdings LLP - Delaware Wellington Management Company LLP - Delaware (d) Title of Class of Securities Common Stock (e) CUSIP Number 23282W605 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Com

View Full Filing

View this SC 13G/A filing on SEC EDGAR